Intestinal Microbiota Signatures Associated with Histological Liver Steatosis in Pediatric-Onset Intestinal Failure

Journal of Parenteral and Enteral Nutrition

Volumn 41, Issue 2, 2017, Pages 238-248

  Korpela, Katri ^a   Mutanen, Annika ^b   Salonen, Anne ^a   Savilahti, Erkki ^b   De Vos, Willem M ^a   Pakarinen, Mikko P ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

Lactobacilli; liver disease; parenteral nutrition; Proteobacteria; short bowel syndrome

Indexed keywords

AMOXICILLIN; BIOLOGICAL MARKER; CALGRANULIN; CIPROFLOXACIN; CLAVULANIC ACID; ERYTHROMYCIN; GELATINASE B; METRONIDAZOLE; NORFLOXACIN; ANTIINFECTIVE AGENT;

ACTINOBACTERIA; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CHILD; CHOLESTASIS; CLINICAL ARTICLE; CLOSTRIDIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTERITIS; ENTEROCOLITIS; FATTY LIVER; FECES; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINAL DYSMOTILITY; INTESTINAL FAILURE; INTESTINE ATRESIA; INTESTINE FLORA; INTESTINE INFECTION; INTESTINE VOLVULUS; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LIVER FIBROSIS; LIVER INJURY; MALE; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS OF VARIANCE; NECROTIZING ENTEROCOLITIS; PARENTERAL NUTRITION; PHYLOGENY; PRIORITY JOURNAL; PROTEOBACTERIA; SCHOOL CHILD; SHORT BOWEL SYNDROME; SMALL INTESTINE; SPECIES DIVERSITY; SPECIES RICHNESS; CALORIC INTAKE; COMPLICATION; ENTEROPATHY; GROWTH, DEVELOPMENT AND AGING; INTESTINE; LIPID METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD;

ACTINOBACTERIA; ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM; ENERGY INTAKE; FATTY LIVER; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL DISEASES; INTESTINES; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LIPID METABOLISM; MALE; PARENTERAL NUTRITION; PROTEOBACTERIA;

EID: 85011562636     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607115584388     Document Type: Article

References (60)

1. Goulet O, Ruemmele F,. Causes and management of intestinal failure in children. Gastroenterology. 2006; 130: S16-S28.
2. D'Antiga L, Goulet O,. Intestinal failure in children: the European view. J Pediatr Gastroenterol Nutr. 2013; 56: 118-126.
3. Scolapio J, Camilleri M, Fleming C,. Gastrointestinal motility considerations in patients with short-bowel syndrome. Dig Dis. 1997; 15: 253-262.
4. Almond S, Haveliwala Z, Khalil B, Morabito A,. Autologous intestinal reconstructive surgery to reduce bowel dilatation improves intestinal adaptation in children with short bowel syndrome. J Pediatr Gastroenterol Nutr. 2013; 56: 631-634.
5. Joly F, Mayeur C, Bruneau A, et al. Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome. Biochimie. 2010; 92: 753-761.
6. Demehri F, Barrett M, Ralls M, Miyasaka E, Feng Y, Teitelbaum D,. Intestinal epithelial cell apoptosis and loss of barrier function in the setting of altered microbiota with enteral nutrient deprivation. Front Cell Infect Microbiol. 2013; 23: 105.
7. Mayeur C, Gratadoux J, Bridonneau C, et al. Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS One. 2013; 8: e54335.
8. Buchman AL, Moukarzel AA, Bhuta S, et al. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr. 1995; 19: 453-460.
9. D'Antiga L, Dhawan A, Davenport M, Mieli-Vergani G, Bjarnason I,. Intestinal absorption and permeability in paediatric short-bowel syndrome: a pilot study. J Pediatr Gastroenterol Nutr. 1999; 29: 588-593.
10. Kaufman S, Loseke C, Lupo J, et al. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr. 1997; 131: 356-361.
11. Pironi L, Goulet O, Buchman A, et al. Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN. Clin Nutr. 2012; 31: 831-845.
12. Lacaille F, Gupte G, Colomb V, et al. Intestinal failure-associated liver disease: a position paper by the ESPGHAN working group of intestinal failure and intestinal transplantation. J Pediatr Gastroenterol Nutr. 2015; 60 (2): 272-283.
13. Mutanen A, Lohi J, Heikkilä P, Koivusalo A, Rintala R, Pakarinen M,. Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure. Hepatology. 2013; 58: 729-738.
14. Mutanen A, Heikkilä P, Lohi J, Raivio T, Jalanko H, Pakarinen M,. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure. J Hepatol. 2014; 60: 183-190.
15. Pereira-Fantini P, Lapthorne S, Joyce S, et al. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease. J Hepatol. 2014; 61: 1115-1125.
16. Schnabl B, Brenner D,. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014; 146: 1513-1524.
17. Raman M, Ahmed I, Gillevet P, et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013; 11: 868-875.
18. Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009; 49: 1877-1887.
19. Gutierrez I, Kang K, Calvert C, et al. Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review. J Pediatr Surg. 2012; 47: 1150-1154.
20. Struijs M, Diamond I, de Silva N, Wales P,. Establishing norms for intestinal length in children. J Pediatr Surg. 2009; 44: 933-938.
21. Saari A, Sankilampi U, Hannila M, Kiviniemi V, Kesseli K, Dunkel L,. New Finnish growth references for children and adolescents aged 0 to 20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med. 2011; 43: 235-248.
22. Wai C, Greenson J, Fontana R, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38: 518-526.
23. Kuitunen M, Kukkonen K, Juntunen-Backman K, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009; 123: 335-341.
24. Kumpu M, Kekkonen R, Kautiainen H, et al. Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr. 2012; 66: 1020-1023.
25. Lahti L, Salonen A, Kekkonen R, et al. Associations between the human intestinal microbiota, lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. PeerJ. 2013; 26: e32.
26. Salonen A, Nikkilä J, Jalanka-Tuovinen J, et al. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods. 2010; 81: 127-134.
27. Rajilić-Stojanović M, Heilig H, Molenaar D, et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol. 2009; 11: 1736-1751.
28. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C: the METAVIR cooperative study group. Hepatology. 1996; 24: 289-293.
29. Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E,. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol. 2005; 16: 65-71.
30. Ralls MW, Miyasaka E, Teitelbaum DH,. Intestinal microbial diversity and perioperative complications. JPEN J Parenter Enteral Nutr. 2014; 38: 392-399.
31. Raetz C, Whitfield C,. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002; 71: 700.
32. Nolan J,. Intestinalendotoxins as mediators of hepatic injury-an idea whose time has come again. Hepatology. 1989; 10: 887-891.
33. Ziegler T, Luo M, Estívariz C, et al. Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome. Am J Physiol Regul Integr Comp Physiol. 2008; 294: R402-R410.
34. Pappo I, Becovier H, Berry E, Freund H,. Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat. J Surg Res. 1991; 51: 112.
35. Pappo I, Bercovier H, Berry E, Haviv Y, Gallily R, Freund H,. Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide. JPEN J Parenter Enteral Nutr. 1992; 16: 529-532.
36. Abu-Shanab A, Quigley E,. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010; 7: 691-701.
37. Alverdy J, Chi H, Sheldon G,. The effect of parenteral nutrition on gastrointestinal immunity: the importance of enteral stimulation. Ann Surg. 1985; 202: 681-684.
38. Alverdy J, Aoys E, Moss G,. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery. 1988; 104: 185-190.
39. Li J, Kudsk K, Gocinski B, Dent D, Glezer J, Langkamp-Henken B,. Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue. J Trauma. 1995; 39: 44-51.
40. Caldarini M, Pons S, D'Agostino D, et al. Abnormal fecal flora in a patient with short bowel syndrome: an in vitro study on effect of pH on D-lactic acid production. Dig Dis Sci. 1996; 41: 1649-1652.
41. Bongaerts G, Tolboom J, Naber A, et al. Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic academia. Microb Pathog. 1997; 22: 285-293.
42. Bongaerts G, Bakkeren J, Severijnen R, et al. Lactobacilli and acidosis in children with short small bowel. J Pediatr Gastroenterol Nutr. 2000; 30: 288-293.
43. Kaneko T, Bando Y, Kurihara H, Satomi K, Nonoyama K, Matsuura N,. Fecal microflora in a patient with short-bowel syndrome and identification of dominant lactobacilli. J Clin Microbiol. 1997; 35: 3181-3185.
44. Hojo K, Bando Y, Itoh Y, Taketomo N, Ishii M,. Abnormal fecal lactobacillus flora and vitamin B12 deficiency in a patient with short bowel syndrome. J Pediatr Gastroenterol Nutr. 2008; 46: 342-345.
45. Sommovilla J, Zhou Y, Sun R, et al. Small bowel resection induces long-term changes in the enteric microbiota of mice. J Gastrointest Surg. 2015; 19: 56-64.
46. Hammes W, Hertel C,. The genera lactobacillus and carnobacterium. In: Dworkin M, Falkow S, Rosenberg E, Schleifer K, Stackebrandt E, eds. The Procaryotes. 3rd ed. New York: Springer; 2006: 320-403.
47. Belenguer A, Holtrop G, Duncan S, et al. Rates of production and utilization of lactate by microbial communities from the human colon. FEMS Microbiol Ecol. 2011; 77: 107-119.
48. Uchida H, Yamamoto H, Kisaki Y, Fujino J, Ishimaru Y, Ikeda H,. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg. 2004; 39: 634-636.
49. Ruiz L, Margolles A, Sánchez B,. Bile resistance mechanisms in lactobacillus and bifidobacterium. Front Microbiol. 2013; 24: 396.
50. Dawson P, Karpen S,. Intestinal transport and metabolism of bile acids. [published online 10, 2014 ]. J Lipid Res.
51. de Aguiar Vallim T, Tarling E, Edwards P,. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013; 17: 657-669.
52. Ohkohchi N, Andoh T, Izumi U, Igarashi Y, Ohi R,. Disorder of bile acid metabolism in children with short bowel syndrome. J Gastroenterol. 1997; 32: 472-479.
53. Keitel V, Häussinger D,. Perspective: TGR5 (gpbar-1) in liver physiology and disease. Clin Res Hepatol Gastroenterol. 2012; 36: 412-419.
54. Spaeth G, Berg R, Specian R, Deitch E,. Food without fiber promotes bacterial translocation from the gut. Surgery. 1990; 108: 240-246.
55. Duncan S, Louis P, Thomson J, Flint H,. The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol. 2009; 11: 2112-2122.
56. Dibaise J, Young R, Vanderhoof J,. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol. 2006; 4: 11-20.
57. Dobson R, McGuckin C, Walker G, et al. Cycled enteral antibiotics reduce sepsis rates in paediatric patients on long-term parenteral nutrition for intestinal failure. Aliment Pharmacol Ther. 2011; 34: 1005-1011.
58. Pakarinen MP, Kurvinen A, Gylling H, et al. Cholesterol metabolism in pediatric short bowel syndrome after weaning off parenteral nutrition. Dig Liver Dis. 2010; 42: 554-559.
59. Schoorel E, Giesberts M, Blom W, van Gelderen H,. D-lactic acidosis in a boy with short bowel syndrome. Arch Dis Child. 1980; 55: 810-812.
60. de Vos W,. Fame and future of faecal transplantations-developing next-generation therapies with synthetic microbiomes. Microb Biotechnol. 2013; 6: 316-325.